Study S001566

A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Investigate the Effect of Taspoglutide on Gastric Emptying Measured by a Paracetamol Test After Single Dose and After Multiple Doses in Patients With Type 2 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT00809705
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: COMPLETED
Enrollment: 60
Start: 2008-12
Primary completion: 2009-10
Lead sponsor: Hoffmann-La Roche
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG:Placebo; DRUG:taspoglutide
Results posted: FALSE
Secondary identifiers: OTHER:2008-003575-47; NIH:2008

Registered primary outcomes

Tmax, log (AUC), log(Cmax)of paracetamol [Days -1, 1, 5, 29, 33, 78 and 82]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.